Bristol-Myers Squibb Company

BMY

$44.66

Name : Bristol-Myers Squibb Company

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $90,902,560,768.00

EPSttm : 2.49

Bristol-Myers Squibb Company

$44.66

1.06%

$0.48

Float Short %

1.45

Margin Of Safety %

Put/Call OI Ratio

0.87

EPS Next Q Diff

0.11

EPS Last/This Y

5.37

EPS This/Next Y

-0.5

Price

44.63

Target Price

52.35

Analyst Recom

2.62

Performance Q

-6.29

Relative Volume

0.95

Beta

0.34

Ticker: BMY

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	BMY	46.72	0.85	0.91	719694
2025-09-09	BMY	47.23	0.86	0.73	728363
2025-09-10	BMY	47.15	0.86	1.02	736253
2025-09-11	BMY	47.54	0.86	4.05	742025
2025-09-12	BMY	46.21	0.85	0.59	744254
2025-09-15	BMY	46.37	0.87	0.44	731171
2025-09-16	BMY	46.33	0.87	0.87	740284
2025-09-17	BMY	46.15	0.87393435928783	1.2980681965513	748024
2025-09-18	BMY	45.57	0.88	1.33	754683
2025-09-19	BMY	45.01	0.89	2.07	764843
2025-09-22	BMY	44.97	0.89	0.29	578543
2025-09-23	BMY	44.9	0.86	0.24	600468
2025-09-24	BMY	44.16	0.83	1.09	621571
2025-09-25	BMY	43.4	0.84	0.67	635754
2025-09-26	BMY	44.1	0.84	0.45	647214
2025-09-29	BMY	44.03	0.87	0.66	630185
2025-09-30	BMY	45.09	0.87	0.37	650573
2025-10-01	BMY	47.42	0.85	0.27	676474
2025-10-02	BMY	45.76	0.85	0.18	716347
2025-10-03	BMY	45.44	0.88	0.50	731507
2025-10-06	BMY	45.12	0.87	0.54	708945
2025-10-07	BMY	44.66	0.87	0.58	738205
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	BMY	46.72	-6.2	5436.0	6.53
2025-09-09	BMY	47.24	-6.2	5638.1	6.53
2025-09-10	BMY	47.15	-6.2	5509.3	6.52
2025-09-11	BMY	47.54	-6.2	5610.3	6.52
2025-09-12	BMY	46.21	-6.2	5242.3	6.52
2025-09-15	BMY	46.37	-6.2	5563.5	6.52
2025-09-16	BMY	46.34	-6.2	5524.3	6.55
2025-09-17	BMY	46.15	-6.2	5485.0	6.55
2025-09-18	BMY	45.57	-6.2	5399.7	6.52
2025-09-19	BMY	45.02	-6.2	5398.5	6.52
2025-09-22	BMY	44.98	-6.2	5517.6	6.52
2025-09-23	BMY	44.90	-6.2	5508.5	6.52
2025-09-24	BMY	44.15	-6.2	5356.9	6.52
2025-09-25	BMY	43.41	-6.2	5357.2	6.52
2025-09-26	BMY	44.12	-6.2	5688.7	6.52
2025-09-29	BMY	44.12	-6.2	5525.3	6.52
2025-09-30	BMY	45.09	-6.2	5738.5	6.52
2025-10-01	BMY	47.41	-6.2	6039.9	6.52
2025-10-02	BMY	45.75	-6.2	5166.2	6.52
2025-10-03	BMY	45.43	-6.2	5460.4	6.52
2025-10-06	BMY	45.12	-6.5	5528.7	6.52
2025-10-07	BMY	44.63	-6.5	5414.2	6.52
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	BMY	-4.10	0.72	1.46
2025-09-09	BMY	-4.10	0.72	1.46
2025-09-10	BMY	-4.10	0.72	1.46
2025-09-11	BMY	-4.10	0.72	1.53
2025-09-12	BMY	-4.10	0.72	1.53
2025-09-15	BMY	-4.10	0.79	1.53
2025-09-16	BMY	-4.10	0.79	1.53
2025-09-17	BMY	-4.10	0.79	1.53
2025-09-18	BMY	-4.10	0.79	1.53
2025-09-19	BMY	-4.10	0.79	1.53
2025-09-22	BMY	-4.10	0.78	1.53
2025-09-23	BMY	-4.10	0.78	1.53
2025-09-24	BMY	-4.10	0.78	1.53
2025-09-25	BMY	-4.10	0.78	1.45
2025-09-26	BMY	-4.10	0.78	1.45
2025-09-29	BMY	-4.10	0.74	1.45
2025-09-30	BMY	-4.10	0.74	1.45
2025-10-01	BMY	-4.10	0.74	1.45
2025-10-02	BMY	-4.10	0.74	1.45
2025-10-03	BMY	-4.10	0.74	1.45
2025-10-06	BMY	-4.10	0.61	1.45
2025-10-07	BMY	-4.10	0.61	1.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.46

Avg. EPS Est. Current Quarter

1.69

Avg. EPS Est. Next Quarter

1.57

Insider Transactions

-4.1

Institutional Transactions

0.61

Beta

0.34

Average Sales Estimate Current Quarter

11754

Average Sales Estimate Next Quarter

12010

Fair Value

60.69

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

45.2

Max Drawdown 5-Year %

-47.7

Target Price

52.35

P/E

18.02

Forward P/E

7.41

PEG

0.25

P/S

1.91

P/B

5.21

P/Free Cash Flow

6.24

EPS

2.48

Average EPS Est. Cur. Y

6.52

EPS Next Y. (Est.)

6.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.58

Relative Volume

0.95

Return on Equity vs Sector %

3.8

Return on Equity vs Industry %

-4.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

5414.2

Bristol-Myers Squibb Company

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 34100

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

stock quote shares BMY – Bristol-Myers Squibb Company Stock Price stock today

news today BMY – Bristol-Myers Squibb Company stock forecast ,stock prediction 2023 2024 2025

marketwatch BMY – Bristol-Myers Squibb Company yahoo finance google finance

stock history BMY – Bristol-Myers Squibb Company invest stock market

stock prices BMY premarket after hours

ticker BMY fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BMY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y